Image Credit: Nemes Laszlo/Shutterstock.com Contact stirring, however, demonstrates just one type of stress that can occur ...

Antibody profiling tools enhance immunology research, offering insights into humoral responses and vaccine efficacy through ...

A study presented at UEG Week 2024 has uncovered distinct antibody responses in Crohn's disease and ulcerative colitis before ...

A combinatorial approach enabled researchers to develop antibodies with improved catch-and-release abilities against snake ...

An example of targeted therapy is antibody-drug conjugates (ADCs), which ... outcomes for patients across many different cancer types. ADCs may be about to change the landscape of cancer ...

A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...

A growing number of American adults have weakened immune systems, which can leave them vulnerable to severe illnesses.

These breakthrough therapies have not only improved survival rates but also provided more targeted, less invasive options.

The company has set high expectations for depemokimab, which it is also advancing in three other inflammatory diseases, including asthma.

Daiichi Sankyo and AstraZeneca's ENHERTU has been conditionally approved by China's NMPA for a specific type of NSCLC.